Olema Pharmaceuticals Stock (NASDAQ: OLMA) stock price, news, charts, stock research, profile.
Open | $14.47 |
Close | $15.15 |
Volume / Avg. | 616.06K / 963.24K |
Day Range | 14.28 - 15.28 |
52 Wk Range | 7.78 - 17.79 |
Market Cap | $828.38M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 20.18% |
Days to Cover | 6.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Olema Pharmaceuticals (NASDAQ:OLMA) through any online brokerage.
Other companies in Olema Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), 89bio (NASDAQ:ETNB), 4D Molecular Therapeutics (NASDAQ:FDMT) and Cogent Biosciences (NASDAQ:COGT).
There is no analysis for Olema Pharmaceuticals.
Olema Pharmaceuticals has a consensus price target of $21.14.
The stock price for Olema Pharmaceuticals (NASDAQ: OLMA) is $14.81 last updated July 22, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Olema Pharmaceuticals.
Olema Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
There is no upcoming split for Olema Pharmaceuticals.
Olema Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.